Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Filings indexed 1,018 across all filing types
Latest filing 2017-03-06 Director's Dealing
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2017-03-06 English
PRIMARY DOCUMENT
Director's Dealing
2017-03-06 English
PRIMARY DOCUMENT
Director's Dealing
2017-03-02 English
PRIMARY DOCUMENT
Director's Dealing
2017-03-01 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on compensation arrangements, including the approval of a Management Incentive Plan, amendments to long-term incentive policies, and director compensation policies. It details executive and director compensation plans and policies rather than providing a full annual or quarterly financial report, earnings release, or other types of filings. The key section is Item 5.02, which relates to departure or election of directors or officers and compensatory arrangements. This aligns with announcements about changes or updates in management compensation and policies. Therefore, the document fits best under the category of Board/Management Information (MANG), which includes announcements of changes in the company's board or senior management and related compensation arrangements. The document length is substantial and contains detailed policy information, not just a brief announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2017-02-24 English
PRIMARY DOCUMENT
Director's Dealing
2017-02-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.